AnaptysBio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AnaptysBio and other ETFs, options, and stocks.

About ANAB

AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab. 

CEO
Daniel R. Faga
CEODaniel R. Faga
Employees
136
Employees136
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2005
Founded2005
Employees
136
Employees136

ANAB Key Statistics

Market cap
761.25M
Market cap761.25M
Price-Earnings ratio
-5.51
Price-Earnings ratio-5.51
Dividend yield
Dividend yield
Average volume
521.17K
Average volume521.17K
High today
$26.92
High today$26.92
Low today
$25.84
Low today$25.84
Open price
$26.73
Open price$26.73
Volume
287.85K
Volume287.85K
52 Week high
$41.31
52 Week high$41.31
52 Week low
$12.21
52 Week low$12.21

ANAB News

Simply Wall St 3d
AnaptysBio, Inc.'s Share Price Not Quite Adding Up

With a median price-to-sales (or "P/S") ratio of close to 8.6x in the Biotechs industry in the United States, you could be forgiven for feeling indifferent abou...

AnaptysBio, Inc.'s Share Price Not Quite Adding Up

Analyst ratings

83%

of 12 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

People also own

Based on the portfolios of people who own ANAB. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.